Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stockwatch: Pantomime Season Comes Early

This article was originally published in Scrip

Executive Summary

The critiques and revelations surrounding the business practices of Valeant Pharmaceuticals International Inc. continued last week with a second successive Monday morning press conference to refute some of the more recent accusations levelled against it. This was followed by a Friday morning marathon press conference held by one of its biggest hedge fund shareholders in an attempt to recover some of the value lost from the fund's Valeant holding. The revelations and refutations concerning Valeant have come to resemble a pantomime with the company in the role of villain, and the list of traditional pantomime characters was bolstered by companies reporting their third-quarter earnings last week.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts